Guardant Health, Inc. (GH)
Guardant Health, Inc. reported revenue of $982.02M for the fiscal year ended Dec 31, 2025, up 32.9% from $739.02M the year before. Net income was a loss of $416.28M, a net margin of -42.4% (prior year: −$436.37M). At the end of that fiscal year the company reported total assets of $2.01B and shareholders' equity of −$99.31M.
Revenue
$982.02M
+32.9% vs prior year
Net income
−$416.28M
Net margin -42.4%
Diluted EPS
−$3.32
USD per share
Total assets
$2.01B
At Dec 31, 2025
Equity
−$99.31M
At Dec 31, 2025
Shares outstanding
134M
As of Jul 24, 2026
Explore Guardant Health, Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Jul 30, 2026
- 10-QFiled May 7, 2026
- 10-KFiled Feb 19, 2026
- 10-QFiled Oct 29, 2025
- 10-QFiled Jul 30, 2025
- 10-QFiled Apr 30, 2025
Source: SEC EDGAR XBRL company facts for CIK 1576280 (raw data). Most recent filing in this dataset: 10-Q filed Jul 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.